GROSSMAN ADAM S (President and CEO) reported 1 transaction at ADMA BIOLOGICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/2/2026ACC: 0001140361-26-007406
DirectorOfficer· President and CEO
Since Feb 2026
-54.86K
Net shares
Net seller
$832.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
54.86K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−54.86K
Price / share
$15.18
Trade value
$832.74K
% of position
2.4%
2/26/2026
2.26M→2.20M
Total
Net shares
−54.86K
Net value
-$832.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | F · Tax Withholding | −54.86K | $15.18 | $832.74K | 2.4% | 2.26M | 2.20M |
| Total | −54.86K | -$832.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.14M
Common Stock
IndirectShares owned580.96K
Total
1.72M indirect1.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.14M | Indirect |
| Common Stock | 580.96K | Indirect |
| Total | 1.72M | 1.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported